Acorda Therapeutics
Business Services · New York, United States · 111 Employees
View Company Info for Free
About
Headquarters
2 Blue Hill Plz Fl 3, Pearl River, New York, 10...Phone Number
(914) 347-4300Website
www.acorda.comRevenue
$111.1 MillionStock Symbol
ACORIndustry
Recent News & Media
Highlights
$430.5M
Total Funding Amount
$5M
Most Recent Funding Amount
8
Number of Funding Rounds
Who is Acorda Therapeutics
Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. They are based in New York.Read more
Popular SearchesACORDA THERAPEUTICS IncAcorda TherapeuticsACORD CorpAcordAcordatherapeutics IncSIC Code 38,382NAICS Code 33,339Ticker NASDAQ: ACORShow moreAcorda Therapeutics Org Chart
Similar Companies to Acorda Therapeutics
- 290$211.9M
1
- 48$10.5M
2
- 299$450M
3
- 103$18.5M
4
- 213$90.5M
5
- 112$10.1M
6
Acorda Therapeutics Company Metrics
$430.5M
Total Funding Amount
$5M
Most Recent Funding Amount
8
Number of Funding Rounds
Jan 29, 2012
Civitas Therapeutics
Oct 09, 2010
Neuronex
Nov 20, 2009
Biotie Therapies
Synosia Therapeutics
See More Acquisitions & Subsidiaries
Acorda Therapeutics Tech Stack
A closer look at the technologies used by Acorda Therapeutics
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Acorda Therapeutics News & Media
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025Acorda Therapeutics Reports Third Quarter 2023 Financial Results
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Reports Third Quarter 2023 Financial ResultsAcorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®
PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®
Frequently Asked Questions regarding Acorda Therapeutics
Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. They are based in New York.... Read More